HIV/AIDS continues to be a major global health problem, with a worldwide estimate by the CDC of 38 million people with HIV. HIV viral load (VL) test measures the number of HIV-1 RNA per mL of blood. The test is a marker of antiretroviral treatment (ART) efficacy and adherence to treatment, which is critical for disease management. About 22 million people with HIV are on ART; however, existing HIV VL tests are not suitable for use at the point-of-care (POC) in resource limited settings. These systems are expensive, require reliable electricity, and skilled operator training. Hence, there is an urgent demand for HIV VL testing at POC to decentralize ART monitoring. The goal of this SBIR Phase I project is to demonstrate feasibility of rapid HIV-1 VL quantification from a finger stick, using methods suitable for POC. This project combines Redbud Labs's microfluidic solutions enabling faster, smaller molecular testing with the HIV detection expertise of the Diagnostics Program at PATH (Seattle, WA). PATH has demonstrated a reverse transcriptase Recombinase Polymerase Amplification (RT-RPA) assay to rapidly amplify HIV-1 RNA and DNA. This assay is dependent on efficient mixing for maximum sensitivity and accuracy. We will combine PATH's work on HIV-1 detection with our microfluidic mixer (MXR) and novel blood tool for blood fractionation. We will demonstrate each step of the protocol from sample processing (i.e., blood stabilization, fractionation, and nucleic acid extraction) to detection on-cartridge. The successful completion of this project will position us to develop a sample-to-answer system in Phase II. The public health impact of this work is significant in the effort to meet the UNAIDS goal of 90% viral suppression by 2020.

Public Health Relevance

UNAIDS has recently set a goal to end the AIDS epidemic by 2030, and as a result, antiretroviral therapy programs are expected to be scaled up, increasing the demand for viral load tests particularly in resource- limited settings. Our Phase I work will demonstrate the feasibility of on-cartridge end-to-end sample processing and rapid HIV viral load detection for use at the point of care.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI145580-01
Application #
9778148
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Petrakova, Eva
Project Start
2019-08-01
Project End
2020-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Redbud Labs, Inc.
Department
Type
DUNS #
965191476
City
Durham
State
NC
Country
United States
Zip Code
27709